These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 6274270

  • 1. Is there any diagnostic relevance of human antibodies which react with mouse mammary tumor virus (MuMTV)?
    Zotter S, Grossmann H, Johannsen BA, Pilz C.
    Arch Geschwulstforsch; 1981; 51(4):338-43. PubMed ID: 6274270
    [Abstract] [Full Text] [Related]

  • 2. Implications of humoral antibody in mice and humans to breast tumor and mouse mammary tumor virus-associated antigens.
    Bowen JM, Dmochowski L, Miller MF, Priori ES, Seman G, Dodson ML, Maruyama K.
    Cancer Res; 1976 Feb; 36(2 pt 2):759-64. PubMed ID: 175935
    [Abstract] [Full Text] [Related]

  • 3. Murine mammary tumor virus seroepidemiology in BALB/cfC3H mice: correlation with tumor development.
    Altrock BW, Cardiff RD, Blair PB.
    J Natl Cancer Inst; 1981 Jul; 67(1):163-8. PubMed ID: 6265680
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Presence of the p27 antigenicity and absence of the gp52 antigenicity and leukemia virus antigens in intracytoplasmic A particles (iAp) of mouse mammary tumour origin.
    Zotter S, Kryukowa IN, Bukrinskaya AG, Lezhnewa OM, Ilyin KV, Miller GG, Müller M.
    Arch Geschwulstforsch; 1976 Jul; 46(8):621-9. PubMed ID: 66045
    [Abstract] [Full Text] [Related]

  • 11. Dependence of initiation of an innocent bystander cytotoxicity reaction on the association of viral antigens and tumor cell membranes in mice.
    Lopez DM, Lopez PF, Parks WP, Paul RD.
    J Natl Cancer Inst; 1986 May; 76(5):923-31. PubMed ID: 2871214
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Immunoelectron microscopic studies of antibodies in mouse sera directed against mouse mammary tumor virus.
    Miller MF, Dmochowski L, Bowen JM.
    Cancer Res; 1977 Jul; 37(7 Pt 1):2086-91. PubMed ID: 193633
    [Abstract] [Full Text] [Related]

  • 15. Comparative studies of purified subviral component vaccines and formalin-treated mammary tumor viruses from four inbred strains of mice.
    Girardi AJ, Dion AS, Pomenti AA, Holben JA.
    J Natl Cancer Inst; 1985 Feb; 74(2):405-13. PubMed ID: 2983136
    [Abstract] [Full Text] [Related]

  • 16. Kinetics of responses to tumor antigens and mouse mammary tumor virus in BALB/cCrgl and BALB/cfC3H mice.
    Lopez DM, Sigel MM, Charyulu VL.
    J Natl Cancer Inst; 1981 Jan; 66(1):191-6. PubMed ID: 6256573
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Ubiquity of natural antibodies to the mammary tumour virus in mice.
    Bentvelzen P, Brinkhof J.
    Arch Geschwulstforsch; 1980 Jan; 50(3):193-203. PubMed ID: 6254462
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Immunization of mice against murine mammary tumor virus infection and mammary tumor development.
    Sarkar NH, Moore DH.
    Cancer Res; 1978 May; 38(5):1468-72. PubMed ID: 205366
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.